Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for M-CMV infected Nicotiana tabacum (Study ST000497)

Reversed phase NEGATIVE ION MODE (Analysis AN000764)

Metabolite	Structure	F1	F2	F3	F4	F5	F6	F7
5-oxoproline	ME155856	0.63	1.29	0.57	1.39	0.69	2.14	2.16
histidine	ME155862	0.37	0.63	0.63	2.20	0.71	2.68	2.96
coumaroylquinate	ME155860	0.52	0.89	2.00	0.67	1.71	2.59	1.04
2-isopropylmalate	ME155853	0.93	2.35	0.46	1.24	0.55	1.47	0.38
sucrose	ME155870	1.01	3.14	0.18	0.85	0.36	1.04	0.37
2-myristoylglycerol (2-monomyristin)	ME155854	1.02	1.15	0.94	0.69	0.29	1.13	1.69
phosphoethanolamine	ME155866	0.93	0.45	1.19	1.27	1.51	0.66	1.32
1-oleoylglycerophosphoglycerol*	ME155845	1.28	1.03	0.80	0.54	0.33	1.29	0.36
anthraniloyl-O-glucose	ME155858	1.16	0.84	0.84	0.84	0.84	0.84	0.84
valylleucine	ME155873	1.29	1.07	0.68	0.66	0.52	0.66	0.66
malonate (propanedioate)	ME155865	0.89	1.18	1.23	1.06	0.93	1.28	1.00
cytidine	ME155861	0.87	1.22	1.02	1.21	0.86	1.17	1.28
uridine	ME155872	0.83	1.31	0.87	1.30	0.88	1.29	1.36
3-butenylglucosinolate	ME155855	1.00	0.94	0.94	1.32	0.94	0.94	0.94
pyridoxate	ME155867	0.88	1.26	0.99	1.21	1.37	1.00	0.89
salidroside	ME155868	0.96	0.98	1.17	0.99	1.30	1.08	0.69
2-hydroxydecanoate	ME155851	1.10	0.77	0.75	1.56	1.24	0.68	0.39
undecanedioate	ME155871	1.00	0.93	0.88	1.14	1.27	1.41	0.36
azelate (nonanedioate)	ME155859	0.96	1.04	0.92	1.49	1.14	1.30	0.33
sebacate (decanedioate)	ME155869	0.93	1.15	0.77	1.53	1.17	1.39	0.43
9,10-epoxystearate	ME155857	0.73	1.24	0.66	1.84	0.69	2.81	0.37
1-palmitoylglycerophosphoglycerol*	ME155848	1.04	1.44	0.64	0.71	0.24	1.98	0.75
linoleate (18:2n6)	ME155863	1.07	1.47	0.56	0.47	0.45	2.07	0.55
linolenate [alpha or gamma; (18:3n3 or 6)]	ME155864	1.18	1.27	0.59	0.35	0.42	1.96	0.33
1-linoleoylglycerol (1-monolinolein)	ME155844	0.83	1.16	0.63	0.70	0.90	2.76	0.84
1-palmitoylglycerophosphoethanolamine	ME155847	0.82	1.26	0.63	0.93	0.37	2.73	1.18
1-palmitoylglycerophosphoinositol*	ME155849	0.43	0.65	0.57	0.41	0.28	6.67	0.85
2-hydroxypalmitate	ME155852	0.93	0.95	0.49	0.51	0.30	3.66	0.50
13-HODE + 9-HODE	ME155850	0.61	1.27	0.69	0.95	0.51	4.00	0.92
1-palmitoylglycerophosphate	ME155846	0.69	0.80	0.70	0.59	0.36	4.49	0.90

Factors:

F1	Treatment:control \| Sample_description:-
F2	Treatment:Infected \| Sample_description:complete green recovery
F3	Treatment:Infected \| Sample_description:mosaic
F4	Treatment:Infected \| Sample_description:patial green recovery
F5	Treatment:Infected \| Sample_description:secondary mosaic
F6	Treatment:Infected \| Sample_description:vein clearing
F7	Treatment:Infected \| Sample_description:white chlorosis

Data matrix